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A series of novel 5-arylidene-thiazolidine-2,4-diones derivatives have been synthesized by the Knoevenagel 
condensation of aromatic aldehydes and N-substituted thiazolidinedione-2,4-diones. Use of KAl(SO4)2•12(H2O) i.e. Alum 
for the reaction makes this synthesis facile because of several advantageous factors viz. non-toxicity, efficient catalytic 
ability and cheap cost of alum. Substitution of arylidene moiety at the position 5 on the thiazolidine-2,4-diones nucleus has 
occured using this facile approach. Synthesized derivatives have been characterized using various analytical tools and 
antimicrobial evaluation thereof has been performed against Gram-positive, Gram negative bacteria and a fungal strain. All 
synthesized compounds show moderate to very good activity against the microorganisms that they have been tested against. 
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Thiazolidine is privileged class of compounds having 
many biological activities. Thiazolidine-2,4-dione 
derivatives found as basic pharmacophore for variety 
of biological activities such as antibacterial and 
antifungal1,2, anticancer, analgesic, aldose reductase 
inhibitors3, antiinflammatory, antituberculosis, 
antitumor4, cardiotonic5 and antidiabetic activity6. 
Now a days the group of heterocyclic compounds 
such as thiazolidine-2,4-dione, 2-imino-4-
thiazolidinone, 4-thioxo-thiazolidine-2,4-dione and 2-
thioxo-1,3-thiazolidine- 4-one (rhodanine) have been 
found as an interesting candidate to work on because 
of their pharmacological properties7-12. 
In the recent years, bacterial infections have 
increased considerably. In human civilization, 
bacteria are the main source of most deadly diseases 
and widespread epidemics. Some of the bacterial 
diseases such as tuberculosis, typhus, plague, 
diphtheria, typhoid fever, cholera, dysentery, and 
pneumonia have taken a high toll on humanity13. 
Improper and repeated use of certain antibiotics is the 
main cause of bacterial resistance. Bacteria become 
resistant to chemotherapeutic agents by destruction or 
inactivation of the drug, prevention of the penetration 
of the target site within the microbe and alteration of 
drug target sites14, 15. Furthermore, antimicrobial 
therapy for infection control has been focused due to 
increasing bacterial resistance to antibiotics16. 
Antibiotics are formed synthetically by bacteria and 
fungi which suppressing the growth of 
microorganisms17. At present, new antibiotics are to 
be discovered which are active against multidrug-
resistant. 
Several literature reports are there on thiazolidine 
conjugates where in they showed number of 
biological activities on getting various substituents on 
different positions of thiazolidine ring18. Medicinal 
chemistry is an important field of research for the 
discovery of new active molecules using heterocyclic 
moieties that increases biological activity19. 
Introducing arylidene groups at the position 5 of the 
thiazolidine ring by using alum has also been reported 
where in alum was used as catalyst and was found as 
an effective promoter for the synthesis of 5- arylidine-
2,4- thiazolidinediones20. With this in view strategy 
has been made to synthesize some novel compounds 
based on heterocyclic moiety i.e. thiazolidine and 
evaluation thereof for antimicrobial activity against 
different Gram positive bacteria e.g. Staphylococcus 
Aureus and Streptococcus Pyogenes bacteria, Gram 
negative bacteria e.g. Escherichia Coli and 
Pseudomonas Aeruginosa. Further the synthesized 
conjugates were also studied for their anti fungal 
activity against Candida albicans. To the best of our 
knowledge this is the first time that modification of 
the thiazolidine is carried out using various 




substituents and derivatives were studied for 
antimicrobial evaluation. 
 
Results and Discussion 
Physicochemical properties 
Study indicates the use of solvents is huge in 
Knoevenagel condensation, but herein present study 
the conditions of Knovenagel condensation have been 
customized. The proposed derivatives were 
synthesized by condensation of aromatic aldehydes 
and N-substituted thiazolidinedione-2,4-diones using 
alum yielding 5-arylidene-thiazolidine-2,4-dione 
derivatives. The reactions were carried out in water 
using 10 mol% alum as a catalyst, use of an alum is to 
avoid some hazardous bases and catalyst e.g. 
piperdine, pyridine and some solvents i.e. DMF, 
DMSO and toluene. Several literatures reported the 
use of alum in organic synthesis since it is non toxic, 
cost-effective, eco-friendly and easy to handle as a 
catalyst (Scheme I). The study was carried out using 
different catalytic amount of alum as shown in 
Table I. There was no change in time but % yield 
decreased with 15 mol% alum. On decreasing the 
amount of alum (5 mol%), the reaction time increases 
and the %yield decreases. The final products given  
in Table II with their physical and chemical 
characteristics which highlights that the compound 
having hydroxyl groups, nitro, methoxy and halogen 
groups, go through smooth reactions.  
The prograss of reaction was monitored by thin 
layer chromatography (TLC) which is step wise given 
in the general synthesis procedure. All the melting 
points were taken after the recryslization of 
compound and are given in Table II. 
 
Antimicrobial evaluation 
The synthesized compounds were evaluated for 
their antimicrobial activity against Gram positive and 
Gram negative bacteria. The results of antibacterial 
and antifungal activity of 5- arylidene-thiazolidine-
2,4-dione derivatives are reported in Table III, in 
 
 
Scheme I — Synthesis of derivatives 4. Reagents and conditions: (a) H2O, 1 h stirring, 4 h reflux; (b) K2CO3, DCM, addition at 0° and 
stirring, 6 h RT stirring; (c) K2CO3, Acetone, reflux, DMF, NaHCO3, RT, 6-7 h; (d) Alum (10 mol%), H2O 
Table I — Reaction condition for the synthesized compound  
with catalyst under different mol% 
Entry Catalyst (mol%) Solvent Time (min) Yield (%) 
1 Alum (5) H2O 90 78 
2 Alum (10) H2O 60 90 
3 Alum (15) H2O 60 84 





comparison with standard drugs, ciprofloxacin and 
ketoconazole. It has been demonstrated that the 
placing of arylidine moieties at position 5 of the 
thiazolidine ring enhanced the antimicrobial activity. 
Inclusion of electron-withdrawing group such as 
halogen and nitro on phenyl ring increase the activity. 
Compounds 4j, 4k, 4l, 4n which have halogens and 
nitro groups showed moderate activity towards  
S. Aureus and S. Pyogenes whereas good activity 
against E. Coli and P. Aeruginosa. Compounds 4e, 4f, 
4g, 4h, 4i having methoxy and hydroxyl group 
exhibited moderate activity against E.Coli and 
P.Aeruginosa. Compounds 4a, 4m, 4o showed poor 
activity against all organisms. The compounds 4b, 4c, 
4d have chlorine atoms which improving the 
lipophilicity of the compound showed excellent 
activities against all tested strains. Most of the 
compounds exhibited moderate antifungal activity. 
 
Experimental Section 
Materials and methods 
All the chemicals (chloro acetic acid, thiourea,  
4- fluroaniline, chloroacetyl chloride, potassium 
carbonate, DCM, DMF, Sodium bicarbonate, acetone, 
methanol, ethyl acetate) used were supplied by SD 
fine and were used directly without further 
purification. Thin layer chromatography (TLC) was 
performed to monitor the reaction progress by using 
silica gel 60F254 plates. Melting points of the 
synthesizes compound were measured in an open 
capillary in a paraffin bath.  
 
Instrumental analysis 
IR spectra of the synthesized derivatives were 
recorded on perkin-Elmer FT Spectrophotometer. 
1H NMR spectra of the compounds were recorded on 
FT-NMR spectrometer model Bruker Avance-II  
400 NMR Spectrometer, using dimethylsulfoxide-d6 
as solvent. The chemical shifts were reported in  
δ units (ppm). The following abbreviation have been 
used s (singlet), d (doublet), t (triplet), m (multiplet) 
for indicate the peak multiplicity in 1H NMR data. 
 
General synthesis procedure 
Synthesis of 2,4-thiazolidinedione, 1 
To a 250 mL three neck flask outfitted with a 
thermometer, a stirrer and a condenser were added 2-
chloroacetic acid (37.8 g, 0.4 mol), thiourea (30.4 g, 
0.4 mol) and water (100 mL). This mixture was 
stirred at RT for at least 1 h, and then was heated to 
reflux. The progress of the reaction was monitored by 
TLC (elution: chloroform-methanol: 20:1) until the 
reaction was complete (3 h). Then the solution was 
allowed to cool down at RT. The large amount of pale 
yellow crystalline solid was filtered and washed with 
water. It was recrystalized from water (decolorized 
with active carbon) to give pure white crystals. Yield: 
79%, mp. 124 –125˚C. 
 
Synthesis of 2-chloro-N-(4-fluorophenyl)a cetamide, 2 
To a well stirred solution of p-fluoro aniline (1.13 
mL, 0.0106 mol) and K2CO3 (5.24 g, 0.038 mol) in 
dry CH2Cl2 (40 mL), chloroacetyl chloride (1 mL, 
0.0126 mol) was added drop wise at 0˚C. The mixture 
was stirred at RT for 6-7 h. After completion of the 
reaction, excess DCM was evaporated in rotary 
Table II — Characterization data of the synthesized compounds 
Compd Aldehyde Time (min) Yield (%) m.p. (°C) 
4a 
 
60 90 210 
4b 
 
70 87 225 
4c 
 
70 85 212 
4d 
 
60 88 220 
4e 
 
80 85 258 
4f 
 
70 86 240 
4g 
 
80 83 200 
4h 
 
90 80 215 
4i 
 
80 83 265 
4j 
 
60 89 230 
4k 
 
70 87 240 
4l 
 
90 82 250 
4m 
 
80 85 262 
4n 
 
60 89 276 
4o 
 
90 80 235 




evaporator. The solid formed was collected and 
washed with excess of water and crystallized by using 
methanol/acetone. Yield: 80%, mp. 134 - 136˚C. 
 
Synthesis of 2- (2,4-dioxothiazolidin-3-yl) -N-  
(4-fluorophenyl) acetamide, 3 
A mixture of thiazolidine-2,4-dione (0.88 g, 0.0075 
mol), 2-chloro-N-(4-fluorophenyl)acetamide (0.93 g, 
0.005mol) and sodium bicarbonate (0.84 g, 0.01mol) 
were dissolved in DMF (15 mL) and stirred at RT for 
overnight. After completion of the reaction as 
confirmation by TLC (eluent 7:3/hexane–ethyl 
acetate) the reaction mixture was poured into water 
(125 mL), extracted with ethyl acetate and the solvent 
distilled under vacuum to obtain solid and crystallized 
by using methanol/acetone. Yield: 80%, mp. 189 - 
190˚C. 
 
Synthesis of 5-benzylidene-2,4-thiazolidinedione 
derivatives, 4 
A mixture of aromatic aldehyde (0.001 mol),  
2-(2,4-dioxothiazolidin-3-yl)-N-(4-fluorophenyl) 
acetamide (0.001 mol), and water (10 mL) were taken 
in flask and to this alum (10 mol%) was added. The 
reaction mixture was heated to reflux for the 
appropriate time given in Table II. The progress of 
reaction was monitored by TLC using ethyl acetate: 
n-hexane (1:9) as a solvent system. After the 
completion of the reaction, the mixture was cooled to 
RT and poured into crushed ice, stirred, and the solid 
product obtained, was filtered, and recrystalized from 
ethanol to give 5-benzylidene-2,4-thiazolidenedione 
4a-o in good to excellent yield. 
 
Spectral analysis 
FT-IR and 1H NMR spectral analysis 
Spectroscopic analysis were carried out for the 
optimized product and spectra for the synthesized 
compounds were compared to that of reference. 
Detailed discussion on the spectral analysis of some 
selected compounds given below. 
2-(5-Benzylidene-2,4-dioxothiazolidin-3-yl)-N-
(4-fluorophenyl)acetamide, 4a: IR (KBr): 2957 (CH, 
aliphatic), 3038 (CH, aromatic), 1735 (C=O), 1580 
(C=C), 690 (CS), 1175 (CN), 3250 cm−1 (NH); 
1H NMR (400 MHz, DMSO-d6): δ 4.52 (s, 2H, CH2), 
7.98 (s, 1H, -CH=), 10.34 (s, 1H, NH), 7.33-7.60 (m, 
5H, Ar-H), 7.60 (d, 2H, Ar-H), 7.22 (d, 2H, Ar-H). 
2-(5-(4-Chlorobenzylidene)-2,4-dioxothiazolidin-
3-yl)-N-(4-fluorophenyl)acetamide, 4b: IR (KBr): 
2945 (CH, aliphatic), 3035 (CH, aromatic), 1733 
(C=O), 1590 (C=C), 695 (CS), 1160 (CN), 3220 
(NH), 738 cm−1 (CCl); 1H NMR (400 MHz, DMSO-
d6): δ 4.64 (s, 2H, CH2), 8.32 (s, 1H, -CH=), 10.45 (s, 
1H, NH), 7.69 (d, 2H, Ar-H), 7.34 (d, 2H, Ar-H), 7.68 
(d, 2H, Ar-H), 7.44 (d, 2H, Ar-H). 
Table III — Antimicrobial activity of the synthesized compound 4a-o as Minimum inhibitory concentration  
(MIC) in µg/mL 
  Gram positive bacteria Gram negative bacteria Fungi 
Compd Ar S.Aureus S.Pyogenes E.Coli P.Aeruginosa C.albicans 
4a H 64 32 64 64 16 
4b 4-Cl 4 4 8 8 16 
4c 3-Cl 8 8 8 8 16 
4d 2,4-Cl 4 4 4 8 8 
4e 4-OCH3 32 64 16 32 32 
4f 3-OCH3 32 64 16 32 16 
4g 4-OH 64 32 32 16 32 
4h 3-OH 64 32 32 16 16 
4i 4-OH, 3-OCH3 32 64 16 16 16 
4j 4-NO2 16 16 8 8 16 
4k 3-NO2 16 16 8 8 16 
4l 4-Br 16 16 8 8 32 
4m 4-CH3 32 32 64 32 16 
4n 4-F 8 8 16 16 16 
4o CH=CH2 32 64 32 64 16 
Ciprofloxacin  4 4 4 4 - 
Ketoconazole  - - - - 4 
S.A. : S.Aureus, S.P. : S.P.yogenes, E.C. : E.Coli, P.A. : P.Aeruginosa, C.a. : C.albicans - Not tested 






3-yl)-N-(4-fluorophenyl)acetamide, 4d: IR (KBr): 
2955 (CH, aliphatic), 3064 (CH, aromatic), 1745 
(C=O), 1590 (C=C), 685 (CS), 1170 (CN), 3235 
(NH), 748 cm−1 (CCl); 1H NMR (400 MHz, DMSO-
d6): δ 4.75 (s, 2H, CH2), 8.36 (s, 1H, -CH=), 10.34 (s, 
1H, NH), 7.48 (s, 1H, Ar-H), 7.32 (d, 1H, Ar-H), 7.61 
(d, 1H, Ar-H), 7.60 (d, 2H, Ar-H), 7.22 (d, 2H, Ar-H). 
N-(4-Fluorophenyl)-2-(5-(3-methoxy–
benzylidene)-2,4-dioxothiazolidin-3-yl)acetamide, 
4f: IR (KBr): 2935 (CH, aliphatic), 3055 (CH, 
aromatic), 1735 (C=O), 1595 (C=C), 690 (CS), 1175 
(CN), 3240 (NH), 1270 cm−1 (COC); 1H NMR (400 
MHz, DMSO-d6): δ 4.86 (s, 2H, CH2), 8.36 (s, 1H, -
CH=), 10.55 (s, 1H, NH), 3.87 (s, 3H, OCH3), 7.20 
(s,1H, Ar-H), 7.13 (d,1H, Ar-H), 7.44 (t, 1H, Ar-H), 
7.19 (d, 1H, Ar-H), 7.65 (d, 2H, Ar-H), 7.26 (d, 2H, 
Ar-H). 
N-(4-Fluorophenyl)-2-(5-(4-nitrobenzylidene)-
2,4-dioxothiazolidin-3-yl)acetamide, 4j: IR (KBr): 
2945 (CH, aliphatic), 3044 (CH, aromatic), 1733 
(C=O), 1590 (C=C), 695 (CS), 1170 (CN), 3250 
(NH), 1530 cm−1 (NO); 1H NMR (400 MHz, DMSO-
d6): δ 4.77 (s, 2H, CH2), 8.22 (s, 1H, -CH=), 10.82 (s, 
1H, NH), 8.15 (d, 2H, Ar-H), 8.34 (d, 2H, Ar-H), 7.58 
(d, 2H, Ar-H), 7.34 (d, 2H, Ar-H). 
 
Antimicrobial activity 
The newly synthesized compounds were evaluated 
for their antibacterial activity by Broth Dilution 
Method. It is one of the non automated in vitro 
bacterial susceptibility tests. This classic method 
yields a quantitative result for the amount of 
antimicrobial agents that is needed to inhibit growth 
of specific microorganisms. It is carried out in tubes. 
Staphylococcus Aureus (MTCC 96) and 
Streptococcus Pyogenes (MTCC 96) from Gram 
positive group of bacteria and Escherichia Coli 
(MTCC 443) and Pseudomonas Aeruginosa (MTCC 
1688) from Gram negative group of bacteria for 
antibacterial activity and yest Candida albicans 
(MTCC 227) used for evaluation of antifungal 
activity. All MTCC Cultures were tested against 
synthesized and reference standard drugs. Mueller 
Hinton Broth was used as nutrient medium to grow 
and dilute the drug suspension for the test bacteria. 
Inoculum size for test strain was adjusted to 108 Cfu 
[Colony Forming Unit] per milliliter by comparing 
the turbidity. Ciprofloxacin was used as the reference 
standard for antibacterial activity and Ketoconazole 
was used as the reference standard for antifungal 
activity. DMSO was used as diluents to get desired 
concentration of drugs to test upon standard bacterial 
strains. 
Serial dilutions were prepared in primary and 
secondary screening. The control tube containing no 
antibiotic is immediately sub cultured [before 
inoculation] by spreading a loopful evenly over a 
quarter of plate of medium suitable for the growth of 
the test organism and put for incubation at 37ºC 
overnight. The tubes are then incubated overnight. 
The MIC of the control organism was read to check 
the accuracy of the drug concentrations. The lowest 
concentration inhibiting growth of the organism was 
recorded as the MIC. The amount of growth from the 
control tube before incubation [which represents the 
original inoculum] was compared. 
Each synthesized drug was diluted obtaining 2000 
microgram /mL concentration, as a stock solution. In 
primary screening 1000 micro/mL, 500 micro/mL, 
and 250 micro/mL concentrations of the synthesized 
drugs were taken. The active synthesized drugs found 
in this primary screening were further diluted to 
obtain 200 micro/mL 100 micro/mL, 50 micro/mL, 25 
micro/mL, 12.5 micro/mL, 6.250 micro/mL, and 
concentrations for secondary screening. The highest 
dilution showing at least 99 % inhibition zone was 
taken as MIC.  
 
Conclusions 
A series of innovative 5-arylidene-thiazolidine-2,4-
diones were synthesized by the knoevenagel 
condensation using alum as a catalyst. All compounds 
were tested against Gram-positive, Gram-negative 
bacteria and C. albicans. Synthesized compounds 
were characterized in terms of physicochemical 
characterization and also by using some different 
analytical techniques i.e. IR and 1H NMR 
spectroscopy. Present study showed a sort of 
structural function relationship amongst the 
synthesized derivatives. It was noted that the 
compounds containing chlorine in the molecule 
showed the excellent antibacterial activity that 
indicates the potential of chlorine towards the 
bacteria. Furthermore, it is to be noted that attaching 
an electron-withdrawing functional group e.g. halogen 
or nitro on phenyl ring played a crucial role to 
enhance the activity. In conclusion, the present study 
revealed a facile method to synthesize a proposed  
5-arylidene-thiazolidine-2,4-diones conjugates using 




alum as a catalyst. In addition the proposed method is 
having many advantages e.g. easy work up procedure, 
better yields, reduced reaction time. Furthermore, the 
catalyst used is easily available, cost-effective, non-
toxic and eco-friendly. 
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